Peripheral Vascular Disease
📧 Sign up to get email alerts when something new happens for Peripheral Vascular Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-02-09Clinical Trial Update: Effect of HPIPC for the Treatment of Ischemic Ulcers in Subjects With PAD [NA]
A completed clinical trial evaluating HPIPC for the treatment of ischemic ulcers in subjects with peripheral artery disease, with results po…
-
CLINICAL_TRIALS trial_result · 2011-09-05Clinical Trial Update: A Study to Collect Intravascular Ultrasound Images Before and After Treatment With the Jetstream System [Phase 4]
A Phase 4 clinical trial evaluating intravascular ultrasound imaging before and after treatment with the Jetstream System has completed data…
-
CLINICAL_TRIALS trial_result · 2011-08-19Clinical Trial Update: Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers [Phase 2]
Phase 2 trial evaluating hepatocyte growth factor via plasmid vector to improve perfusion in critical limb ischemia with peripheral ischemic…
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia [Phase 1, Phase 2]
Phase 1/2 trial evaluating autologous CD34-positive cell injections for critical limb ischemia has completed, involving patients with periph…
-
CLINICAL_TRIALS trial_result · 2011-04-28Clinical Trial Update: Combination Stem Cell Therapy for the Treatment of Severe Leg Ischemia [Phase 1]
Phase 1 clinical trial evaluating a combination stem cell therapy for severe leg ischemia has completed the study, with status reported as c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2011-04-06Clinical Trial Update: Autologous Bone Marrow Stem Cell Transplantation for Critical, Limb-threatening Ischemia [Phase 2, Phase 3]
Clinical trial update on autologous bone marrow stem cell transplantation for critical limb-threatening ischemia, evaluated in Phase 2 and P…
-
CLINICAL_TRIALS research · 2011-03-16Clinical Trial Update: A Prospective Study to Assess the Screening Value of N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) for the Identification of Patients That Benefit From Additional Cardiac Testing Prior to Vascular Surgery [NA]
A prospective study evaluating NT-proBNP as a screening tool to identify patients who would benefit from additional cardiac testing before v…
-
CLINICAL_TRIALS trial_result · 2011-03-11Clinical Trial Update: The Complete® Self-Expanding Stent and Stent Delivery System Registry [NA]
This clinical trial registry update reports completion and results posting for Medtronic Endovascular's Complete Self-Expanding Stent and St…
-
CLINICAL_TRIALS trial_result · 2011-03-10Clinical Trial Update: A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral Stent System [NA]
This completed clinical trial evaluated the safety and efficacy of the Dynalink-E Everolimus-eluting peripheral stent system for patients wi…
-
EMA withdrawal · 2011-02-28EMA Withdrawn: Clopidogrel 1A Pharma (clopidogrel) — Acino Pharma GmbH
EMA has withdrawn Clopidogrel 1A Pharma (clopidogrel) from Acino Pharma GmbH.
-
CLINICAL_TRIALS trial_result · 2011-01-19Clinical Trial Update: Placement of Peripherally Inserted Central Venous Catheters (PICC) in Children Guided by Ultrasound [NA]
A completed clinical trial from the Federal University of São Paulo evaluating ultrasound-guided placement of peripherally inserted central …
-
CLINICAL_TRIALS trial_result · 2010-12-01Clinical Trial Update: DURABILITY-200: EverFlex 200mm Long Nitinol Stents in TASC C&D Femoropopliteal Lesions [Phase 4]
Phase 4 trial update showing completion of the DURABILITY-200 study evaluating EverFlex 200 mm nitinol stents in TASC C&D femoropopliteal le…
-
CLINICAL_TRIALS trial_result · 2010-11-16Clinical Trial Update: Femoral Arterial Access With Ultrasound Trial [NA]
Completed clinical trial evaluating ultrasound-guided femoral arterial access with results posted.
-
CLINICAL_TRIALS trial_result · 2010-09-13Clinical Trial Update: Screening DIVA - Diffuse Vascular Disease
This document notes that the Screening DIVA trial for Diffuse Vascular Disease, sponsored by Sanofi, has completed.
-
CLINICAL_TRIALS other · 2010-06-08Clinical Trial Update: SAMBA EU Femoropopliteal Trial [NA]
An update on the SAMBA EU Femoropopliteal trial sponsored by NovoStent for Peripheral Vascular Disease. The current trial status is unknown.
-
CLINICAL_TRIALS trial_result · 2010-05-21Clinical Trial Update: Effect of VascuActive Device on Foot Perfusion, Hemodynamics and Exercise Capacity in Patients With PVD & Limb Ischemia [NA]
A completed clinical study evaluating the VascuActive device's impact on foot perfusion, hemodynamics, and exercise capacity in patients wit…
-
CLINICAL_TRIALS trial_result · 2010-03-30Clinical Trial Update: Testosterone Replacement in Diabetes With Vascular Disease (Version 2) [Phase 4]
A Phase 4 clinical trial update on testosterone replacement in adults with diabetes mellitus and peripheral vascular disease; the study stat…
-
CLINICAL_TRIALS trial_result · 2010-01-06Clinical Trial Update: SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System [Phase 3]
Phase 3 clinical trial SPIRIT FIRST evaluating the XIENCE V Everolimus-eluting coronary stent system by Abbott has completed.
-
CLINICAL_TRIALS trial_result · 2009-12-17Clinical Trial Update: Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion [Phase 2]
Phase 2 clinical trial of Alfimeprase for thrombolysis in acute peripheral arterial occlusion has completed.
-
CLINICAL_TRIALS trial_result · 2009-09-29Clinical Trial Update: Warfarin and Antiplatelet Vascular Evaluation [Phase 3]
Phase 3 clinical trial evaluating warfarin with antiplatelet therapy for peripheral vascular disease and cardiovascular disease; current sta…
-
CLINICAL_TRIALS research · 2009-09-03Clinical Trial Update: VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management
Update on a pharmacogenomics study examining how VKORC1 and CYP2C9 polymorphisms affect warfarin management across several indications, incl…
-
CLINICAL_TRIALS trial_result · 2009-08-11Clinical Trial Update: Assessment of the Clinical Utility of Non Invasive Peripheral Signal Averaged Pulse Volume
Completed clinical trial evaluating the clinical utility of non-invasive peripheral signal-averaged pulse volume in assessing peripheral vas…
-
CLINICAL_TRIALS trial_result · 2009-07-31Clinical Trial Update: Study of the SafeSeal(TM) Hemostasis Patch Following Percutaneous Coronary Artery and Peripheral Vascular Interventions [Phase 4]
This document provides an update on a Phase 4 clinical trial evaluating the SafeSeal Hemostasis Patch used after percutaneous coronary and p…
-
CLINICAL_TRIALS trial_result · 2009-05-14Clinical Trial Update: ALD-301 for Critical Limb Ischemia, Randomized Trial [Phase 1, Phase 2]
ALD-301 was evaluated in a randomized Phase 1/2 trial for critical limb ischemia and peripheral arterial disease. The study status is comple…
-
EMA withdrawal · 2009-04-23EMA Application withdrawn: Clopidogrel Teva Pharma (clopidogrel) — Teva Pharma B.V.
The EMA application for Clopidogrel Teva Pharma (clopidogrel) has been withdrawn.